Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Latest From Sanofi

RB Coughs Up For Digital Diagnostic Development

Reckitt will work with former Sanofi partner ResApp to develop a consumer app which can diagnose common respiratory issues. The partnership represents RB's latest move into the digital space for its Health business.

Digital Health OTC Devices

UK Identifies First Recipients Of Future COVID-19 Vaccine

As clinical trials of potential coronavirus vaccines continue, the UK government has drawn up a list of those who should be first in line for vaccination, although it cautions that many unknowns remain in areas such as efficacy, dosing schedules and duration of protection.

United Kingdom Coronavirus COVID-19

Sanofi At Heart Of Plan To Return Paracetamol Production To France

Production of paracetamol will return to France after a more than 10 year absence in an initiative spearheaded by President Macron to avoid future shortages.

Manufacturing OTC Drugs

OTC Decisions In May: Esomeprazole For Sun Pharma, Guaifenesin For Granules India, More NRTs For PLD During Slow Month For Approvals

CDER representative says staff’s time available for drug applications currently is affected by the FDA having employees work remotely in response to the novel coronavirus pandemic.

OTC Drugs FDA
See All

Company Information

UsernamePublicRestriction

Register